Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04888975 · ClinicalTrials.gov registry record · NA

A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery

A NA study of Lymphedema and Lymphedema Arm, sponsored by Koya Medical.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT04888975 is a NA study of Lymphedema and Lymphedema Arm that is actively recruiting participants, run by Koya Medical. The registered enrollment target is 20 participants, below the 9,299-participant average among 34 other Lymphedema trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04888975, a NA study of Lymphedema and Lymphedema Arm, is actively recruiting participants, sponsored by Koya Medical.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

To evaluate the Dayspring Active Wearable Compression Technology in enhancing lymph movement and its safety and effectiveness after lymphatic surgery

Interventions

  • DEVICE Dayspring Active Wearable Compression System

Study Locations (1)

California

  • Dung Nguyen, MD, PharmD - Palo Alto

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2021-06-01
Est. Completion 2021-12-31
Phase NA

Sponsor

Koya Medical

7 total trials

What the Registry Record Tells You About NCT04888975

The ClinicalTrials.gov registry entry for NCT04888975 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 9,299-participant average among 34 other Lymphedema trials with a reported enrollment target (100% lower). The listed sponsor is Koya Medical, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Lymphedema appearing as the primary indexed condition, and to 1 intervention - of which Dayspring Active Wearable Compression System is the first listed.

NCT04888975 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04888975 about?

NCT04888975 is a clinical study titled "A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery". To evaluate the Dayspring Active Wearable Compression Technology in enhancing lymph movement and its safety and effectiveness after lymphatic surgery

What is the current status of trial NCT04888975?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2021-06-01. Estimated completion is 2021-12-31.

What conditions does trial NCT04888975 study?

This clinical trial studies the following conditions: Lymphedema, Lymphedema Arm, Lymphedema, Breast Cancer.

What interventions are being tested in trial NCT04888975?

The interventions under investigation include: Dayspring Active Wearable Compression System (DEVICE).

Who is sponsoring clinical trial NCT04888975?

This trial is sponsored by Koya Medical, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04888975 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lymphedema

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.